68463-9
LaboratoryRilpivirine [Susceptibility] by Genotype method
Definition
This test refers to sequence-based genotyping of HIV in human plasma infected with the virus to identify genotypic resistance to Rilpivirine. The assay involves the isolation of HIV RNA from blood plasma and amplification of the protease and reverse transcriptase genes. The PCR product is sequenced and analyzed. Genotypic characteristics of the virus are used to predict resistance to Rilipvirine.
LOINC 6-Axis Classification
Component
Rilpivirine
Property
Susc
Time Aspect
Pt
System
Isolate
Scale Type
Ord
Method Type
Genotyping
Details
Class
ABXBACT
Order/Observation
Both
Short Name
Rilpivirine Islt Genotyp
Display Name
Rilpivirine Genotyping [Susc]
Related Names
Frequently Asked Questions
What is LOINC code 68463-9?
LOINC code 68463-9 identifies "Rilpivirine [Susceptibility] by Genotype method". This test refers to sequence-based genotyping of HIV in human plasma infected with the virus to identify genotypic resistance to Rilpivirine. The assay involves the isolation of HIV RNA from blood plasma and amplification of the protease and reverse transcriptase genes. The PCR product is sequenced and analyzed. Genotypic characteristics of the virus are used to predict resistance to Rilipvirine.
What does 68463-9 measure?
This code measures Rilpivirine in Isolate. It belongs to the ABXBACT class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.